ketanserin has been researched along with Deficiency, Thiamine in 3 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Excerpt | Relevance | Reference |
---|---|---|
" Since dietary thiamine deficiency (TD) in mice is considered as a putative model of WKS, it was used in the present study to investigate the function of serotonergic neurons in this disorder." | 3.74 | Enhanced head-twitch response to 5-HT-related agonists in thiamine-deficient mice. ( Arai, Y; Mitazaki, S; Murata, A; Nakagawasai, O; Niijima, F; Ohba, A; Tadano, T; Tan-No, K; Wakui, K, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nakagawasai, O | 1 |
Murata, A | 1 |
Arai, Y | 1 |
Ohba, A | 1 |
Wakui, K | 1 |
Mitazaki, S | 1 |
Niijima, F | 1 |
Tan-No, K | 1 |
Tadano, T | 1 |
Mousseau, DD | 2 |
Rao, VL | 2 |
Butterworth, RF | 2 |
3 other studies available for ketanserin and Deficiency, Thiamine
Article | Year |
---|---|
Enhanced head-twitch response to 5-HT-related agonists in thiamine-deficient mice.
Topics: Amphetamines; Animals; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Toleran | 2007 |
Alterations in serotonin parameters in brain of thiamine-deficient rats are evident prior to the appearance of neurological symptoms.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amines; Animals; Autoradiography; Brain; Brain Chemistry; Ch | 1996 |
Vesicular dysfunction during experimental thiamine deficiency is indicated by alterations in dopamine metabolism.
Topics: Adrenergic Uptake Inhibitors; Animals; Antimetabolites; Autoradiography; Brain Chemistry; Catecholam | 1996 |